DK161492C - Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden

Info

Publication number
DK161492C
DK161492C DK026081A DK26081A DK161492C DK 161492 C DK161492 C DK 161492C DK 026081 A DK026081 A DK 026081A DK 26081 A DK26081 A DK 26081A DK 161492 C DK161492 C DK 161492C
Authority
DK
Denmark
Prior art keywords
bactery
procedure
weaked
vaccine
genetically
Prior art date
Application number
DK026081A
Other languages
Danish (da)
English (en)
Other versions
DK161492B (da
DK26081A (da
Inventor
Max Paul Oeschger
Joseph A Bellanti
Anne Morris Hooke
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of DK26081A publication Critical patent/DK26081A/da
Publication of DK161492B publication Critical patent/DK161492B/da
Application granted granted Critical
Publication of DK161492C publication Critical patent/DK161492C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/21—Haemophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/83—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant bacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/851—Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DK026081A 1979-05-23 1981-01-21 Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden DK161492C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/041,896 US4337314A (en) 1979-05-23 1979-05-23 Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4189679 1979-05-23
US8000613 1980-05-23
PCT/US1980/000613 WO1980002504A1 (en) 1979-05-23 1980-05-23 Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype

Publications (3)

Publication Number Publication Date
DK26081A DK26081A (da) 1981-01-21
DK161492B DK161492B (da) 1991-07-15
DK161492C true DK161492C (da) 1992-01-13

Family

ID=21918924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK026081A DK161492C (da) 1979-05-23 1981-01-21 Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden

Country Status (9)

Country Link
US (1) US4337314A (sv)
EP (1) EP0024956B1 (sv)
JP (1) JPH0440330B2 (sv)
AU (1) AU536370B2 (sv)
DE (1) DE3071115D1 (sv)
DK (1) DK161492C (sv)
IE (1) IE50598B1 (sv)
NZ (1) NZ193815A (sv)
WO (1) WO1980002504A1 (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550081A (en) * 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US5643771A (en) * 1980-05-19 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Non-reverting live bacterial vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4837151A (en) * 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US5135739A (en) * 1983-02-15 1992-08-04 Kitasato Kenkyusho Non-cariogenic composition and drink
US4857318A (en) * 1983-11-07 1989-08-15 Syntex (U.S.A.) Inc. Bordetella bronchiseptica pilus subunit protein vaccine effective against bordetella pertussis
US4764370A (en) * 1984-09-12 1988-08-16 Scripps Clinic And Research Foundation Vaccine utilizing an avirulent strain of Salmonella typhimurium
JPS62502262A (ja) * 1985-03-27 1987-09-03 ブロンコスタット・プロプライアタリー・リミテツド アジユバントを含有しないワクチン
EP0220308A1 (en) * 1985-04-30 1987-05-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
GB8730037D0 (en) * 1987-12-23 1988-02-03 Wellcome Found Vaccines
US5811105A (en) * 1987-12-23 1998-09-22 Glaxo Wellcome, Inc. Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway
US4891210A (en) * 1989-01-03 1990-01-02 Norris Alan H Use of bacteriophages in dental hygiene
US5132220A (en) * 1989-06-30 1992-07-21 The United States Of America As Represented By The Secretary Of Agriculture More virulent biotype isolated from wild-type virus
US4957686A (en) * 1990-02-06 1990-09-18 Norris Alan H Use of bacteriophages to inhibit dental caries
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
DE4041045A1 (de) * 1990-12-20 1992-07-02 Max Planck Gesellschaft Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen
CA2101550A1 (en) * 1991-01-29 1992-07-30 Kakambi V. Nagaraja Live vaccine against colibacillosis
CA2148829A1 (en) * 1992-11-06 1994-05-26 Keum Hwa Choi Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis
US6254874B1 (en) 1995-04-13 2001-07-03 President And Fellows Of Harvard College Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same
US5741680A (en) * 1996-09-03 1998-04-21 Cera Products, Inc. Buffer composition base and method of formulation for oral vaccine delivery
ATE318916T1 (de) * 2002-09-01 2006-03-15 Univ Washington Kontrollierte bakterielle lyse zur verabreichung von dna vakzinvektoren und impfantigen
US8637049B2 (en) * 2011-04-06 2014-01-28 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated live vaccines for aquatic animals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856935A (en) * 1971-04-29 1974-12-24 Schweiz Serum & Impfinst Oral typhoid vaccine and method of preparing the same
US3975517A (en) * 1972-05-25 1976-08-17 Canadian Patents And Development Limited Enteric disease vaccine
US3992522A (en) * 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
US4058599A (en) * 1973-02-24 1977-11-15 Bayer Aktiengesellschaft Ethyleneimine inactivated organisms
US3855408A (en) * 1973-07-16 1974-12-17 Univ Minnesota Poultry vaccine
US4190495A (en) * 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4133875A (en) * 1978-02-23 1979-01-09 Forsyth Dental Infirmary For Children Method of controlling dental caries with streptococcus mutans mutant strains

Also Published As

Publication number Publication date
AU5855680A (en) 1980-11-27
WO1980002504A1 (en) 1980-11-27
NZ193815A (en) 1982-12-21
DK161492B (da) 1991-07-15
DE3071115D1 (en) 1985-10-31
EP0024956B1 (en) 1985-09-25
DK26081A (da) 1981-01-21
IE50598B1 (en) 1986-05-28
JPH0440330B2 (sv) 1992-07-02
US4337314A (en) 1982-06-29
JPS56500612A (sv) 1981-05-07
EP0024956A3 (en) 1981-12-02
EP0024956A2 (en) 1981-03-11
IE801073L (en) 1980-11-23
AU536370B2 (en) 1984-05-03

Similar Documents

Publication Publication Date Title
DK161492C (da) Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden
ES493480A0 (es) Perfeccionamientos en brazos de manipulacion a distancia
DK257780A (da) Anordning ved en fjernvarmeledning samt fremgangsmaade til fremstilling af anordningen
IT1188896B (it) Laminato modellabile a caldo e procedimento per modellarlo
DK151269C (da) Proteinasepraeparat med nedsat allergenicitet, fremgangsmaade til fremstilling heraf samt mikroorganismestammer til anvendelse ved fremstilling heraf
AR222258A1 (es) Mejoras en un acuaplano motorizado
ES498032A0 (es) Perfeccionamientos en los grupos metalurgicos de fusion y reverbero
PT70130A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
NO782170L (no) Fremgangsmaate til haandtering av en person paa et underlag og innretning til utfoerelse av fremgangsmaaten
DK528979A (da) Silicageler fremgangsmaade til deres fremstilling samt deres anvendelse
DK259980A (da) Fremgangsmaade til fremstilling af armerede betongenstande samt anlaeg til brug ved fremgangsmaaden
ES490048A0 (es) Perfeccionamientos en los conjuntos emulsionadores
DK203178A (da) Thiobenzimidazolderivater deres fremstilling og anvendelse samt mellemprodukter ved fremstillingen og fremstilling af saadanne mellemprodukter
NO148270C (no) Fremgangsmaate til utlegning av materialer langs en trase paa havbunnen, system til bruk ved utfoerelse av fremgangsmaaten, og anvendelse av systemet
DK52781A (da) Fremgangsmaade til fremstilling af pigmentpraeparater samt anvendelse deraf
DK148040C (da) Fremgangsmaade til fremstilling af limet papir og limningsmiddel til brug ved fremgangsmaaden
IT1143169B (it) Perfezionamento negli apparecchi laser
DK558083A (da) Somatostatinforbindelse, fremgangsmaade til fremstilling deraf samt mellemprodukt til brug ved udoevelse af fremgangsmaaden
IT1129719B (it) Procedimento di alchilazione di isoparaffine-olefine utilizzante raffreddamento a evaporazione in un reattore-depropanizzatore
DK448880A (da) Beskyttende adhaesivpasta til brug i forbindelse med ostomiindretninger
DK170779A (da) Phenoxyalkyltrialkoxysilaner samt fremgangsmaade til fremstilling heraf
ES255732Y (es) Una cubierta para mangos de raquetas de tenis y similares
DK345677A (da) Fremgangsmade til fremstilling af cyanoprostaglandiner samt mellemprodukt til brug ved fremgangsmaden
SE8002024L (sv) Bryggare
DK430681A (da) Fremgangsmaade til fremstilling af en proeve til endotoxin-bestemmelse samt udstyr til brug ved fremgangsmaaden

Legal Events

Date Code Title Description
PUP Patent expired